Application
SPG7 Antibody (Center) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the SPG7 antibody detected the SPG7 protein (arrow).Application
SPG7 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SPG7 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | SPG7 Antibody (Center) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SPG7; CAR; CMAR; PGN; Paraplegin; Spastic paraplegia 7 protein |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CAR CMAR PGN |
|---|---|
| Alternative Names | SPG7 CAR CMAR PGN Paraplegin Spastic paraplegia 7 protein |
| Molecular Weight(MW) | 88235 Da |
| Function | Putative ATP-dependent zinc metalloprotease. |
| Tissue Specificity | Ubiquitous. |
| Cellular Localization | Mitochondrion membrane; Multi-pass membrane protein |
| Entrez Gene | 6687 |
|---|---|
| Nucleotide Accession | NP_955399.1 NP_003110.1 |
Application
SPG7 Antibody (Center) western blot analysis in 293 cell line lysates (35ug/lane).This demonstrates the SPG7 antibody detected the SPG7 protein (arrow).
Application
SPG7 Antibody (Center) immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of SPG7 Antibody (Center) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
